{
    "nctId": "NCT04312347",
    "briefTitle": "Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels",
    "officialTitle": "Tamoxifen Dose Adjustment on ER+ Breast Cancer Patients Based on Genomic and Metabolite Concentrations Analysis",
    "overallStatus": "COMPLETED",
    "conditions": "ER+ Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 151,
    "primaryOutcomeMeasure": "Effects of genotype and phenotype of CYP2D6 on plasma and serum concentration of tamoxifen and its metabolites",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosed with ER+ breast cancer\n* Have taken tamoxifen daily for at least 2 months\n\nExclusion Criteria:\n\n* Have not taken tamoxifen daily for at least 2 months",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}